A detailed history of Schonfeld Strategic Advisors LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 60,182 shares of AXSM stock, worth $4.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
60,182
Previous 106,842 43.67%
Holding current value
$4.75 Million
Previous $8.5 Million 43.53%
% of portfolio
0.03%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$69.39 - $97.64 $3.24 Million - $4.56 Million
-46,660 Reduced 43.67%
60,182 $4.8 Million
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $2.25 Million - $3.27 Million
39,144 Added 57.82%
106,842 $8.5 Million
Q3 2023

Nov 14, 2023

SELL
$69.25 - $82.21 $527,269 - $625,946
-7,614 Reduced 10.11%
67,698 $4.73 Million
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $3.8 Million - $5.87 Million
64,999 Added 630.26%
75,312 $5.41 Million
Q1 2023

May 15, 2023

SELL
$58.39 - $75.0 $4.32 Million - $5.55 Million
-74,042 Reduced 87.77%
10,313 $636,000
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $1.4 Million - $2.79 Million
34,955 Added 70.76%
84,355 $6.51 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $8,077 - $15,646
-224 Reduced 0.45%
49,400 $2.2 Million
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $920,123 - $1.98 Million
42,324 Added 579.78%
49,624 $1.9 Million
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $173,010 - $302,147
7,300 New
7,300 $302,000
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $40,431 - $57,105
-1,317 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$19.91 - $68.26 $51,427 - $176,315
-2,583 Reduced 66.23%
1,317 $44,000
Q2 2021

Aug 16, 2021

BUY
$50.63 - $73.5 $197,457 - $286,650
3,900 New
3,900 $263,000
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $1.36 Million - $1.71 Million
-19,886 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$49.87 - $98.69 $362,405 - $717,180
7,267 Added 57.59%
19,886 $1.64 Million
Q1 2020

May 15, 2020

SELL
$41.2 - $101.31 $723,842 - $1.78 Million
-17,569 Reduced 58.2%
12,619 $742,000
Q4 2019

Feb 14, 2020

SELL
$16.71 - $106.24 $1.54 Million - $9.81 Million
-92,312 Reduced 75.36%
30,188 $3.12 Million
Q3 2019

Nov 14, 2019

SELL
$20.24 - $29.16 $9.86 Million - $14.2 Million
-487,300 Reduced 79.91%
122,500 $2.48 Million
Q2 2019

Aug 14, 2019

BUY
$13.46 - $25.75 $6.53 Million - $12.5 Million
485,300 Added 389.8%
609,800 $15.7 Million
Q1 2019

May 15, 2019

BUY
$2.63 - $16.34 $327,435 - $2.03 Million
124,500 New
124,500 $1.77 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.38B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.